Table 2. Details of the evaluation of dMMR mutation.
N = 44 | |
Tissues used for dMMR evaluation | |
Primary site | 32 (72.7) |
Metastatic site | 12 (27.3) |
Specimen collection method | |
Core needle biopsy | 28 (63.6) |
Tumor removal | 13 (29.5) |
Primary site | 12 (27.3) |
Metastatic site | 1 (2.3) |
Transurethral resection of the tumor | 3 (6.8) |
Time from specimen collection to notification of results, months (range) | 14 (0–180) |